NASDAQ:CMRA

Comera Life Sciences Holdings Stock Forecast

etoro logo Buy CMRA
*Your capital is at risk
$0.0001
+0 (+0%)
At Close: Jun 22, 2026
Add CMRA to Watchlist?
  • Easy Tracking In The Watchlist

CMRA Performance

FAQ

What is the symbol for Comera Life Sciences Holdings, Inc. Stock and on which exchange is it traded?
The symbol for Comera Life Sciences Holdings, Inc. is CMRA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Comera Life Sciences Holdings, Inc. Stock?
Comera Life Sciences Holdings, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Comera Life Sciences Holdings, Inc. Stock?
Comera Life Sciences Holdings, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Comera Life Sciences Holdings, Inc. Stock.

What's the current price of Comera Life Sciences Holdings, Inc. Stock?
As of the end of day on the Jun 22, 2026, the price of an Comera Life Sciences Holdings, Inc. (CMRA) share was $0.0001.

What is the 52-week high and low for Comera Life Sciences Holdings, Inc. Stock?
The 52-week high for Comera Life Sciences Holdings, Inc. Stock is $0.0002 and the 52-week low is $0.0001000000.

What is the market capitalization of Comera Life Sciences Holdings, Inc. Stock?
As of the Jun 22, 2026, the market capitalization of Comera Life Sciences Holdings, Inc. is 3.074K.
Click to get the best stock tips daily for free!
ABOUT COMERA LIFE SCIENCES HOLDINGS, INC.
Comera Life Sciences Holdings
Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform, SQore. Its SQore platform is designed to enable the conversion of intravenous (IV) biologics to subcutaneous (SQ) versions. The company is advancing its primary product programs, CLS-001, a preclinical stage biobetter for Crohn's and Ulcerative Colitis dis...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.29% Jun 10
PHM
$118.49
6.02% Jun 10
EAT
$140.46
17.09% Jun 05
E
ETD
$20.67
3.19% Jun 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE